Published in Sex Transm Dis on October 01, 2007
Selling sex in unsafe spaces: sex work risk environments in Phnom Penh, Cambodia. Harm Reduct J (2011) 1.34
Offer of financial incentives for unprotected sex in the context of sex work. Drug Alcohol Rev (2010) 1.01
Group sex events amongst non-gay drug users: an understudied risk environment. Int J Drug Policy (2010) 0.91
Reducing sexual risk among Filipina female bar workers: effects of a CBPR-developed structural and network intervention. AIDS Educ Prev (2010) 0.90
Casual sex and concurrent sexual partnerships among young people from an Yi community with a high prevalence of HIV in China. Asian J Androl (2012) 0.88
Violence prevention and municipal licensing of indoor sex work venues in the Greater Vancouver Area: narratives of migrant sex workers, managers and business owners. Cult Health Sex (2015) 0.86
Sexual networks, surveillance, and geographical space during syphilis outbreaks in rural North Carolina. Epidemiology (2012) 0.76
Condoms and sexual health education as evidence: impact of criminalization of in-call venues and managers on migrant sex workers access to HIV/STI prevention in a Canadian setting. BMC Int Health Hum Rights (2016) 0.75
Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ (2003) 4.38
Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med (2007) 4.14
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med (2010) 3.85
Structural and environmental barriers to condom use negotiation with clients among female sex workers: implications for HIV-prevention strategies and policy. Am J Public Health (2009) 3.85
Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell (2010) 3.72
Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ (2002) 3.70
Rationale for evaluating North America's first medically supervised safer-injecting facility. Lancet Infect Dis (2004) 3.20
Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ (2003) 3.19
The Canadian government's treatment of scientific process and evidence: inside the evaluation of North America's first supervised injecting facility. Int J Drug Policy (2008) 3.05
Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology (2002) 2.99
Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS (2002) 2.74
Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America. Influenza Other Respir Viruses (2009) 2.69
The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci U S A (2009) 2.66
Displacement of Canada's largest public illicit drug market in response to a police crackdown. CMAJ (2004) 2.63
Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ (2004) 2.62
The changing age and seasonal profile of pertussis in Canada. J Infect Dis (2002) 2.53
The impact of a police presence on access to needle exchange programs. J Acquir Immune Defic Syndr (2003) 2.37
Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend (2006) 2.33
The importance of social networks in their association to drug equipment sharing among injection drug users: a review. Addiction (2007) 2.32
Hepatitis C virus reinfection in injection drug users. Hepatology (2006) 2.25
A review of barriers and facilitators of HIV treatment among injection drug users. AIDS (2008) 2.21
Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure. CMAJ (2003) 2.18
Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Antivir Ther (2004) 2.14
Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside. CMAJ (2003) 2.08
Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ (2006) 2.06
Expanding access to HAART: a cost-effective approach for treating and preventing HIV. AIDS (2010) 2.04
Community-based HIV prevention research among substance-using women in survival sex work: the Maka Project Partnership. Harm Reduct J (2007) 2.02
Parental intention to have daughters receive the human papillomavirus vaccine. CMAJ (2007) 1.91
Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada. Addiction (2007) 1.90
Attendance at supervised injecting facilities and use of detoxification services. N Engl J Med (2006) 1.83
Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction (2007) 1.81
A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med (2010) 1.81
Modeling control strategies of respiratory pathogens. Emerg Infect Dis (2005) 1.79
Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduct J (2004) 1.77
Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy. J Infect Dis (2003) 1.77
The effect of universal influenza immunization on antibiotic prescriptions: an ecological study. Clin Infect Dis (2009) 1.77
Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia. AIDS (2006) 1.72
Burden of HIV infection among aboriginal injection drug users in Vancouver, British Columbia. Am J Public Health (2008) 1.71
Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. J Acquir Immune Defic Syndr (2002) 1.69
Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai. J Antimicrob Chemother (2006) 1.69
Antibiotic use in children is associated with increased risk of asthma. Pediatrics (2009) 1.68
Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can J Public Health (2003) 1.66
Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug Alcohol Depend (2007) 1.64
Sexual and drug-related vulnerabilities for HIV infection among women engaged in survival sex work in Vancouver, Canada. Can J Public Health (2008) 1.63
Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world. AIDS (2003) 1.63
Sexual violence among a cohort of injection drug users. Soc Sci Med (2003) 1.61
Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. J Infect Dis (2011) 1.61
The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users. J Acquir Immune Defic Syndr (2003) 1.54
Identification of networks of sexually transmitted infection: a molecular, geographic, and social network analysis. J Infect Dis (2005) 1.54
Frequent needle exchange use and HIV incidence in Vancouver, Canada. Am J Med (2007) 1.53
Characteristics of injection drug users who participate in drug dealing: implications for drug policy. J Psychoactive Drugs (2008) 1.53
Do supervised injecting facilities attract higher-risk injection drug users? Am J Prev Med (2005) 1.52
Rats, cities, people, and pathogens: a systematic review and narrative synthesis of literature regarding the ecology of rat-associated zoonoses in urban centers. Vector Borne Zoonotic Dis (2013) 1.52
Requiring help injecting independently predicts incident HIV infection among injection drug users. J Acquir Immune Defic Syndr (2005) 1.48
Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. Can J Gastroenterol (2007) 1.44
Seasonal influenza vaccine and increased risk of pandemic A/H1N1‐related illness: first detection of the association in British Columbia, Canada. Clin Infect Dis (2010) 1.43
Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4. J Cell Biol (2011) 1.42
Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS (2002) 1.41
Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr (2002) 1.38
Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. J Urban Health (2003) 1.38
An external evaluation of a peer-run "unsanctioned" syringe exchange program. J Urban Health (2003) 1.38
Occupational stigma as a primary barrier to health care for street-based sex workers in Canada. Cult Health Sex (2011) 1.37
Access and utilization of HIV treatment and services among women sex workers in Vancouver's Downtown Eastside. J Urban Health (2005) 1.35
Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users. Harm Reduct J (2006) 1.33
Antibiotic use among children in British Columbia, Canada. J Antimicrob Chemother (2006) 1.27
Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility. Am J Public Health (2006) 1.26
Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilization. Addiction (2004) 1.26
Injection drug users' perceptions regarding use of a medically supervised safer injecting facility. Addict Behav (2006) 1.26
Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting. BMC Public Health (2009) 1.25
A dose-response relationship between exposure to a large-scale HIV preventive intervention and consistent condom use with different sexual partners of female sex workers in southern India. BMC Public Health (2011) 1.25
Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime. Subst Abuse Treat Prev Policy (2006) 1.25
Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver. AIDS Patient Care STDS (2009) 1.25
HIV/AIDS in Vancouver, British Columbia: a growing epidemic. Harm Reduct J (2009) 1.24
Slower uptake of HIV antiretroviral therapy among Aboriginal injection drug users. J Infect (2005) 1.21
Conducting HIV/AIDS research with indoor commercial sex workers: reaching a hidden population. Prog Community Health Partnersh (2007) 1.21
Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study. BMC Public Health (2008) 1.20
Transmission patterns of HIV and hepatitis C virus among networks of people who inject drugs. PLoS One (2011) 1.20
Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. CMAJ (2010) 1.18
Hepatitis B immunization strategies: timing is everything. CMAJ (2009) 1.18
HIV and HCV prevalence and gender-specific risk profiles of crack cocaine smokers and dual users of injection drugs. Subst Use Misuse (2008) 1.18
Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada. BMC Public Health (2006) 1.17
Measurement of antibiotic consumption: A practical guide to the use of the Anatomical Thgerapeutic Chemical classification and Definied Daily Dose system methodology in Canada. Can J Infect Dis (2004) 1.17
Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus. J Gen Virol (2006) 1.16
Determinants of cutaneous injection-related infection care at a supervised injecting facility. Ann Epidemiol (2009) 1.14
Chlamydia trachomatis omp1 genotypic diversity and concordance with sexual network data. J Infect Dis (2003) 1.14
Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users. Antivir Ther (2004) 1.12
Prevalence and correlates of Chlamydia infection in Canadian street youth. J Adolesc Health (2004) 1.12
Understanding recruitment: outcomes associated with alternate methods for seed selection in respondent driven sampling. BMC Med Res Methodol (2013) 1.12
Targeted mass treatment for syphilis with oral azithromycin. Lancet (2003) 1.09
Survival sex work involvement as a primary risk factor for hepatitis C virus acquisition in drug-using youths in a canadian setting. Arch Pediatr Adolesc Med (2010) 1.09
Management of HCV and HIV infections among people who inject drugs. Curr Opin HIV AIDS (2011) 1.07
Identifying heterogeneity among injection drug users: a cluster analysis approach. Am J Public Health (2008) 1.07
A description of a peer-run supervised injection site for injection drug users. J Urban Health (2005) 1.06
Impact of universal preadolescent vaccination against hepatitis B on antenatal seroprevalence of hepatitis B markers in British Columbia women. CMAJ (2003) 1.06
Epidemic of group A Streptococcus M/emm59 causing invasive disease in Canada. Clin Infect Dis (2010) 1.06
Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility. Am J Public Health (2007) 1.06